XTX Topco’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $31.4K | Buy |
27,772
+7,026
| +34% | +$7.94K | ﹤0.01% | 2098 |
|
2025
Q1 | $30.3K | Sell |
20,746
-137,791
| -87% | -$201K | ﹤0.01% | 2078 |
|
2024
Q4 | $338K | Buy |
+158,537
| New | +$338K | 0.03% | 1107 |
|
2024
Q2 | – | Sell |
-35,765
| Closed | -$160K | – | 1822 |
|
2024
Q1 | $160K | Buy |
35,765
+379
| +1% | +$1.69K | 0.02% | 1245 |
|
2023
Q4 | $114K | Sell |
35,386
-38,604
| -52% | -$124K | 0.02% | 1102 |
|
2023
Q3 | $235K | Buy |
73,990
+28,159
| +61% | +$89.3K | 0.04% | 916 |
|
2023
Q2 | $228K | Buy |
45,831
+259
| +0.6% | +$1.29K | 0.04% | 923 |
|
2023
Q1 | $225K | Sell |
45,572
-71,264
| -61% | -$352K | 0.05% | 865 |
|
2022
Q4 | $735K | Buy |
116,836
+78,194
| +202% | +$492K | 0.16% | 158 |
|
2022
Q3 | $417K | Buy |
+38,642
| New | +$417K | 0.1% | 319 |
|